h1

h2

h3

h4

h5
h6

001     1008080
005     20251001135038.0
024 7 _ |2 HSB
|a eva591656
024 7 _ |2 ISSN
|a 1664-3224
024 7 _ |2 SCOPUS
|a SCOPUS:2-s2.0-85213678932
024 7 _ |2 WOS
|a WOS:001385304700001
024 7 _ |2 doi
|a 10.3389/fimmu.2024.1321336
024 7 _ |2 pmid
|a pmid:39737169
024 7 _ |2 datacite_doi
|a 10.18154/RWTH-CONV-254459
037 _ _ |a RWTH-CONV-254459
041 _ _ |a English
100 1 _ |0 P:(DE-82)IDM06393
|a Stiehl, Thomas Peter
|b 0
|u rwth
245 _ _ |a Stem cell graft dose and composition could impact on the expansion of donor-derived clones after allogeneic hematopoietic stem cell transplantation – a virtual clinical trial
|h online
260 _ _ |a Lausanne
|b Frontiers Media
|c 2024
336 7 _ |0 0
|2 EndNote
|a Journal Article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
336 7 _ |0 PUB:(DE-HGF)7
|2 PUB:(DE-HGF)
|a Contribution to a book
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
591 _ _ |a Denmark
591 _ _ |a Germany
770 _ _ |a Improving Stem Cell Transplantation Delivery Using Computational Modelling / Editors: Pawan Kumar Raghav, Vinay Randhawa, Eva Maria Weissinger
773 _ _ |0 PERI:(DE-600)2606827-8
|a 10.3389/fimmu.2024.1321336
|p 1-22
|t Frontiers in immunology
|v 15
|x 1664-3224
856 4 _ |u https://publications.rwth-aachen.de/record/1008080/files/1008080.pdf
|y OpenAccess
909 C O |o oai:publications.rwth-aachen.de:1008080
|p dnbdelivery
|p driver
|p VDB
|p open_access
|p openaire
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)IDM06393
|a RWTH Aachen
|b 0
|k RWTH
914 1 _ |y 2024
915 1 _ |0 StatID:(DE-HGF)0031
|2 StatID
|a Peer reviewed article
|x 0
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2024-12-28
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2024-12-28
915 _ _ |0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
|a Creative Commons Attribution CC BY 4.0
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b FRONT IMMUNOL : 2022
|d 2024-12-28
915 _ _ |0 StatID:(DE-HGF)0500
|2 StatID
|a DBCoverage
|b DOAJ
|d 2023-12-29T15:23:07Z
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2024-12-28
915 _ _ |0 StatID:(DE-HGF)0501
|2 StatID
|a DBCoverage
|b DOAJ Seal
|d 2023-12-29T15:23:07Z
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2024-12-28
915 _ _ |0 StatID:(DE-HGF)0700
|2 StatID
|a Fees
|d 2024-12-28
915 _ _ |0 StatID:(DE-HGF)0510
|2 StatID
|a OpenAccess
915 _ _ |0 StatID:(DE-HGF)0561
|2 StatID
|a Article Processing Charges
|d 2024-12-28
915 _ _ |0 StatID:(DE-HGF)9905
|2 StatID
|a IF >= 5
|b FRONT IMMUNOL : 2022
|d 2024-12-28
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2024-12-28
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2024-12-28
920 1 _ |0 I:(DE-82)929420_20210202
|k 929420
|l Institut und Lehr- und Forschungsgebiet Disease Modelling mit Schwerpunkt auf Phasenübergängen zwischen Phänotypen
|x 0
970 _ _ |a eva591656
980 1 _ |a FullTexts
980 _ _ |a I:(DE-82)929420_20210202
980 _ _ |a UNRESTRICTED
980 _ _ |a VDB
980 _ _ |a contb
980 _ _ |a journal

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21